Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
Zernike Meta Ventures (MZV) is a prominent European venture capital firm and innovation consultancy formed as a joint venture between the Dutch Zernike Group and the Italian META Group. The firm specializes in early-stage investments, managing multiple regional co-investment funds across Italy, Slovenia, Poland, and Spain, with a heavy emphasis on life sciences, biotechnology, and medical technology. MZV provides not only essential seed and growth capital but also comprehensive entrepreneurial mentoring and strategic support to bridge the gap between academic research and commercial success. Its portfolio features highly innovative companies in fields such as molecular diagnostics, orthopedic biomimetics, and pediatric oncology. By leveraging its international network and public-private partnerships, MZV plays a critical role in fostering high-growth startups within the European healthcare ecosystem.
Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on Zernike Meta Ventures.